C5a induces A549 cell proliferation of non-small cell lung cancer via GDF15 gene activation mediated by GCN5-dependent KLF5 acetylation
Authors:
Open Access
- 18 May 2018
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 37 (35) , 4821-4837
Abstract
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, and multiple evidence has confirmed that C5a production is elevated in NSCLC microenvironment. Although NSCLC cell proliferation induced by C5a has been reported, the involved mechanism has not been elucidated. In this study, we examined the proliferation-related genes (i.e., KLF5, GCN5, and GDF15) and C5a receptor (C5aR) expression in tumor tissues as well as C5a concentration in plasma of NSCLC patients, and then determined the roles of KLF5, GCN5, and GDF15 in C5a-triggered NSCLC cell proliferation and the related mechanism both in vitro and in vivo. Our results found that the expression of KLF5, GCN5, GDF15, C5aR, and C5a was significantly upregulated in NSCLC patients. Mechanistic exploration in vitro revealed that C5a could facilitate A549 cell proliferation through increasing KLF5, GCN5, and GDF15 expression. Besides, KLF5 and GCN5 could form a complex, binding to GDF15 promoter in a KLF5-dependent manner and leading to GDF15 gene transcription. More importantly, GCN5-mediated KLF5 acetylation contributing to GDF15 gene transcription and cell proliferation upon C5a stimulation, the region (−103 to +58 nt) of GDF15 promoter which KLF5 could bind to, and two new KLF5 lysine sites (K335 and K391) acetylated by GCN5 were identified for the first time. Furthermore, our experiment in vivo demonstrated that the growth of xenograft tumors in BALB/c nude mice was greatly suppressed by the silence of KLF5, GCN5, or GDF15. Collectively, these findings disclose that C5a-driven KLF5–GCN5–GDF15 axis had a critical role in NSCLC proliferation and might serve as targets for NSCLC therapy.Keywords
This publication has 51 references indexed in Scilit:
- Krüppel-Like Factor 5 Promotes Lung Tumorigenesis through Upregulation of Sox4Cellular Physiology and Biochemistry, 2014
- Lysine Acetyltransferase GCN5 Potentiates the Growth of Non-small Cell Lung Cancer via Promotion of E2F1, Cyclin D1, and Cyclin E1 ExpressionJournal of Biological Chemistry, 2013
- Anaphylatoxin C5a Creates a Favorable Microenvironment for Lung Cancer ProgressionThe Journal of Immunology, 2012
- Sublytic C5b‐9 complexes induce proliferative changes of glomerular mesangial cells in rat Thy‐1 nephritis through TRAF6‐mediated PI3K‐dependent Akt1 activationThe Journal of Pathology, 2011
- A Protein Complex Network of Drosophila melanogasterCell, 2011
- Unwelcome ComplementCancer Research, 2009
- Modulation of the antitumor immune response by complementNature Immunology, 2008
- Targeted molecular therapy of anaplastic thyroid carcinoma with AEE788Molecular Cancer Therapeutics, 2005
- GCN5: a supervisor in all-inclusive control of vertebrate cell cycle progression through transcription regulation of various cell cycle-related genesGene, 2005
- Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cellsSurgery, 2004